Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) 

Published byCarol Thornton Modified over 6 years ago

Similar presentations

Presentation on theme: "Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) "— Presentation transcript:

1 Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT)  Omar M. Issa, DO, Rhonda Roberts, MPH, Daniel B. Mark, MD, MPH, Robin Boineau, MD, Christine Goertz, DC, PhD, Yves Rosenberg, MD, MPH, Eldrin F. Lewis, MD, Erminia Guarneri, MD, Jeanne Drisko, MD, Allan Magaziner, DO, Kerry L. Lee, PhD, Gervasio A. Lamas, MD  American Heart Journal  Volume 195, Pages (January 2018) DOI: /j.ahj Copyright © 2017 The Authors Terms and Conditions

2 Figure Outcomes in TACT participants randomized to high dose multivitamins and minerals. A, Kaplan-Meier plot for the primary end point in participants not taking statins by vitamin arm. B, Kaplan-Meier plot for total mortality in participants not taking statins by vitamin arm. C, Kaplan-Meier plot for the primary end point in participants taking statins by vitamin arm. American Heart Journal  , 70-77DOI: ( /j.ahj ) Copyright © 2017 The Authors Terms and Conditions

Download ppt "Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) "

Similar presentations

For the TACT Investigators

For the TACT Investigators
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Volume 366, Issue 9481, Pages (July 2005)

Volume 366, Issue 9481, Pages (July 2005)
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Colloquium on Therapy of Right Heart Failure

Colloquium on Therapy of Right Heart Failure
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7.

Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7.
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.

Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.
Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.
American Heart Journal

American Heart Journal
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation  Anh L. Bui, MD, Maria.

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation  Anh L. Bui, MD, Maria.
Volume 127, Issue 6, Pages (June 2005)

Volume 127, Issue 6, Pages (June 2005)
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Similar presentations

Ads by Google